Condition
Metastatic clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Metastatic clinical trials that are recruiting, at sites in 2 countries (most in United States (2), China (2)). By phase: Phase 1/2 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Metastatic clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Personalized dual-target CAR-T therapy for advanced solid tumors | Phase 1/2 | Shenzhen, Guangdong | Recruiting | Apr 13, 2026 |
| Platform program for evaluating treatments in metastatic HER2-positive breast cancer | Phase 1/2 | Birmingham, Alabama and 9 other locations | Recruiting | May 22, 2023 |
| Combination treatment for metastatic adenocarcinoma of the small intestine or appendix | Phase 2 | Guangzhou, Guangdong | Recruiting | Jul 25, 2022 |
| Combining Sarilumab with Capecitabine for Treating Triple Negative Breast Cancer | Phase 1/2 | Los Angeles, California and 2 other locations | Recruiting | Apr 3, 2020 |
All recruiting trials (4)
-
Personalized dual-target CAR-T therapy for advanced solid tumors
This trial will test personalized dual-target CAR-T cells, matched to tumor biomarker patterns, in adults with advanced unresectable or metastatic solid cancers to see if dual targeting improves tumor control and safety.
-
Platform program for evaluating treatments in metastatic HER2-positive breast cancer
This study is testing different new treatments for people with advanced HER2-positive breast cancer to see which ones work best before moving them to larger trials.
-
Combination treatment for metastatic adenocarcinoma of the small intestine or appendix
This study is testing a new combination of three medications to see if they can help people with advanced cancer of the small intestine or appendix who haven't responded to other treatments.
-
Combining Sarilumab with Capecitabine for Treating Triple Negative Breast Cancer
This study is testing if combining an immunotherapy drug called sarilumab with a chemotherapy drug called capecitabine can help people with advanced triple negative breast cancer or those who still have high-risk disease after initial treatment.
Related topics
Quick answers
How many Metastatic clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), China (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.